Tissue Engineering And Nanotheranostics

“9.61x6.69” b2815 Tissue Engineering and Nanotheranostics

Multifunctional Nanomaterials for Cancer Theranostics 273

221. Schleich N, Po C, Jacobs D, Ucakar B, Gallez B, Danhier F, Preat V.
     Comparison of active, passive and magnetic targeting to tumors of
     multifunctional paclitaxel/SPIO­loaded nanoparticles for tumor imag­
     ing and therapy. J. Control. Rel. 194 , 82–91 (2014).


222. Theek B, Gremse F, Kunjachan S, Fokong S, Pola R, Pechar M,
     Deckers R, Storm G, Ehling J, Kiessling F, Lammers T. Characterizing
     EPR­mediated passive drug targeting using contrast­enhanced func­
     tional ultrasound imaging. J. Control. Rel. 182 , 83–89 (2014).


223. Hirsjarvi S, Passirani C, Benoit JP. Passive and active tumour targeting
     with nanocarriers. Curr. Drug Discovery Technol. 8 , 188–196 (2011).


224. Meng H, Xue M, Xia T, Ji Z, Tarn DY, Zink JI, Nel AE. Use of size
     and a copolymer design feature to improve the biodistribution and the
     enhanced permeability and retention effect of doxorubicin­loaded
     mesoporous silica nanoparticles in a murine xenograft tumor model.
     ACS Nano. 5 , 4131–4144 (2011).


225. Aslan B, Ozpolat B, Sood AK, Lopez­Berestein G. Nanotechnology in
     cancer therapy. J. Drug Target. 21 , 904–913 (2013).


226. Hirsjarvi S, Dufort S, Gravier J, Texier I, Yan Q, Bibette J, Sancey L,
     Josserand V, Passirani C, Benoit JP, Coll JL. Influence of size, surface
     coating and fine chemical composition on the in vitro reactivity and
     in vivo biodistribution of lipid nanocapsules versus lipid nanoemulsions
     in cancer models. Nanomedicine 9 , 375–387 (2013).


227. Agarwal R, Jurney P, Raythatha M, Singh V, Sreenivasan SV, Shi L,
     Roy K. Effect of shape, size, and aspect ratio on nanoparticle penetra­
     tion and distribution inside solid tissues using 3D spheroid models.
     Adv. Health. Mater. 4 , 2269–2280 (2015).


228. Wojnicki M, Luty­Blocho M, Bednarski M, Dudek M, Knutelska J,
     Sapa J, Zygmunt M, Nowak G, Fitzner K. Tissue distribution of gold
     nanoparticles after single intravenous administration in mice. Pharmacol.
     Rep. 65 , 1033–1038 (2013).


229. Kaminskas LM, Boyd BJ, Karellas P, Henderson SA, Giannis MP,
     Krippner GY, Porter CJ. Impact of surface derivatization of poly­L­
     lysine dendrimers with anionic arylsulfonate or succinate groups on
     intravenous pharmacokinetics and disposition. Mole. Pharm. 4 , 949–
     961 (2007).


230. Maeda H. Vascular permeability in cancer and infection as related to
     macromolecular drug delivery, with emphasis on the EPR effect for
     tumor­selective drug targeting, Proceedings of the Japan Academy.
     Series B. Phys. Biol. Sci. 88 , 53–71 (2012).